Morbus Dupuytren: Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte Fortbildung

Dupuytren’s contracture is a fibroproliferative systemic disease that cannot be stopped by medication. The overall prevalence is 7-8%. Men are affected 3-4 times more frequently. The cause of the disease is not known. A genetic disposition and thus familial clustering are being discussed. Risk facto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Harbrecht, Andreas (VerfasserIn) , Honigmann, Philipp (VerfasserIn) , Löw, Steffen (VerfasserIn) , Müller, Lars Peter (VerfasserIn) , Unglaub, Frank (VerfasserIn) , Spies, Christian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Deutsch
Veröffentlicht: November 2024
In: Die Orthopädie
Year: 2024, Jahrgang: 53, Heft: 11, Pages: 893-902
ISSN:2731-7153
DOI:10.1007/s00132-024-04553-z
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00132-024-04553-z
Verlag, lizenzpflichtig, Volltext: http://link.springer.com/article/10.1007/s00132-024-04553-z
Volltext
Verfasserangaben:A. Harbrecht, P. Honigmann, S. Löw, L.P. Müller, F. Unglaub, C.K. Spies

MARC

LEADER 00000caa a2200000 c 4500
001 1915162009
003 DE-627
005 20250716223250.0
007 cr uuu---uuuuu
008 250120s2024 xx |||||o 00| ||ger c
024 7 |a 10.1007/s00132-024-04553-z  |2 doi 
035 |a (DE-627)1915162009 
035 |a (DE-599)KXP1915162009 
035 |a (OCoLC)1528016654 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a ger 
084 |a 33  |2 sdnb 
100 1 |a Harbrecht, Andreas  |d 1989-  |e VerfasserIn  |0 (DE-588)1170173195  |0 (DE-627)1037603621  |0 (DE-576)512407479  |4 aut 
245 1 0 |a Morbus Dupuytren  |b Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte Fortbildung  |c A. Harbrecht, P. Honigmann, S. Löw, L.P. Müller, F. Unglaub, C.K. Spies 
246 1 |i Englischsprachiger Titel der Zusammenfassung  |a Dupuytren’s disease. Epidemiology, diagnosis, treatment, outcome 
264 1 |c November 2024 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online publiziert: 25. September 2024 
500 |a Gesehen am 20.01.2025 
520 |a Dupuytren’s contracture is a fibroproliferative systemic disease that cannot be stopped by medication. The overall prevalence is 7-8%. Men are affected 3-4 times more frequently. The cause of the disease is not known. A genetic disposition and thus familial clustering are being discussed. Risk factors for the development of a Dupuytren’s contracture are work-related stress (microtrauma), nicotine and alcohol consumption, epilepsy and diabetes mellitus as well as advanced age. The prognosis is poor in cases with a positive family history, bilateral involvement, age <50 years and male gender. Several treatment options are available. Conservative therapy has no lasting benefit. Minimally invasive procedures include partial needle aponeurectomy or the injection of collagenase. Surgical procedures range from partial aponeurectomy to dermatoaponeurectomy. The recurrence risk of the gold standard treatment of surgery (partial aponeurectomy) is 20.9%. 
700 1 |a Honigmann, Philipp  |e VerfasserIn  |4 aut 
700 1 |a Löw, Steffen  |d 1972-  |e VerfasserIn  |0 (DE-588)123331994  |0 (DE-627)706259491  |0 (DE-576)293659737  |4 aut 
700 1 |a Müller, Lars Peter  |e VerfasserIn  |0 (DE-588)1113301740  |0 (DE-627)867166231  |0 (DE-576)476943345  |4 aut 
700 1 |a Unglaub, Frank  |d 1974-  |e VerfasserIn  |0 (DE-588)124402518  |0 (DE-627)36332254X  |0 (DE-576)294155422  |4 aut 
700 1 |a Spies, Christian  |d 1977-  |e VerfasserIn  |0 (DE-588)133382516  |0 (DE-627)544038339  |0 (DE-576)299810054  |4 aut 
773 0 8 |i Enthalten in  |t Die Orthopädie  |d [Berlin] : Springer Medizin Verlag GmbH, 2022  |g 53(2024), 11 vom: Nov., Seite 893-902  |h Online-Ressource  |w (DE-627)1808390040  |w (DE-600)3122958-X  |x 2731-7153  |7 nnas  |a Morbus Dupuytren Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte Fortbildung 
773 1 8 |g volume:53  |g year:2024  |g number:11  |g month:11  |g pages:893-902  |g extent:10  |a Morbus Dupuytren Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte Fortbildung 
856 4 0 |u https://doi.org/10.1007/s00132-024-04553-z  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://link.springer.com/article/10.1007/s00132-024-04553-z  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250120 
993 |a Article 
994 |a 2024 
998 |g 124402518  |a Unglaub, Frank  |m 124402518:Unglaub, Frank  |d 60000  |e 60000PU124402518  |k 0/60000/  |p 5 
999 |a KXP-PPN1915162009  |e 4654244921 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1007/s00132-024-04553-z"],"eki":["1915162009"]},"name":{"displayForm":["A. Harbrecht, P. Honigmann, S. Löw, L.P. Müller, F. Unglaub, C.K. Spies"]},"titleAlt":[{"title":"Dupuytren’s disease. Epidemiology, diagnosis, treatment, outcome"}],"physDesc":[{"noteIll":"Illustrationen","extent":"10 S."}],"recId":"1915162009","type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["ger"],"note":["Online publiziert: 25. September 2024","Gesehen am 20.01.2025"],"title":[{"subtitle":"Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte Fortbildung","title":"Morbus Dupuytren","title_sort":"Morbus Dupuytren"}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"November 2024"}],"relHost":[{"pubHistory":["Volume 51, issue 6 (June 2022)-"],"origin":[{"publisherPlace":"[Berlin]","dateIssuedDisp":"[2022]-","publisher":"Springer Medizin Verlag GmbH"}],"note":["Gesehen am 28.06.2022"],"language":["ger","eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"subtitle":"Organ der Deutschen Gesellschaft für Orthopädie und Orthopädische Chirurgie : Organ der Deutschen Gesellschaft für Orthopädie und Unfallchirurgie : Organ der Österreichischen Gesellschaft für Orthopädie und orthopädische Chirurgie","title_sort":"Orthopädie","title":"Die Orthopädie"}],"part":{"volume":"53","year":"2024","extent":"10","text":"53(2024), 11 vom: Nov., Seite 893-902","issue":"11","pages":"893-902"},"id":{"eki":["1808390040"],"issn":["2731-7153"],"zdb":["3122958-X"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"1808390040","disp":"Morbus Dupuytren Epidemiologie, Diagnose, Therapie, Outcome : CME : zertifizierte FortbildungDie Orthopädie"}],"person":[{"family":"Harbrecht","given":"Andreas","role":"aut","display":"Harbrecht, Andreas"},{"display":"Honigmann, Philipp","given":"Philipp","role":"aut","family":"Honigmann"},{"role":"aut","given":"Steffen","family":"Löw","display":"Löw, Steffen"},{"display":"Müller, Lars Peter","role":"aut","given":"Lars Peter","family":"Müller"},{"display":"Unglaub, Frank","family":"Unglaub","given":"Frank","role":"aut"},{"family":"Spies","given":"Christian","role":"aut","display":"Spies, Christian"}]} 
SRT |a HARBRECHTAMORBUSDUPU2024